Toyooka KO - Search Results

1

Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells.

Toyooka S, Carbone M, Toyooka KO, Bocchetta M, Shivapurkar N, Minna JD, Gazdar AF. Toyooka S, et al. Among authors: toyooka ko. Oncogene. 2002 Jun 20;21(27):4340-4. doi: 10.1038/sj.onc.1205381. Oncogene. 2002. PMID: 12082623

2

Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features.

Maruyama R, Toyooka S, Toyooka KO, Virmani AK, Zöchbauer-Müller S, Farinas AJ, Minna JD, McConnell J, Frenkel EP, Gazdar AF. Maruyama R, et al. Among authors: toyooka s, toyooka ko. Clin Cancer Res. 2002 Feb;8(2):514-9. Clin Cancer Res. 2002. PMID: 11839671

3

Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas.

Toyooka S, Toyooka KO, Harada K, Miyajima K, Makarla P, Sathyanarayana UG, Yin J, Sato F, Shivapurkar N, Meltzer SJ, Gazdar AF. Toyooka S, et al. Among authors: toyooka ko. Cancer Res. 2002 Jun 15;62(12):3382-6. Cancer Res. 2002. PMID: 12067979

4

Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.

Harada K, Toyooka S, Maitra A, Maruyama R, Toyooka KO, Timmons CF, Tomlinson GE, Mastrangelo D, Hay RJ, Minna JD, Gazdar AF. Harada K, et al. Among authors: toyooka s, toyooka ko. Oncogene. 2002 Jun 20;21(27):4345-9. doi: 10.1038/sj.onc.1205446. Oncogene. 2002. PMID: 12082624

5

Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation.

Toyooka KO, Toyooka S, Maitra A, Feng Q, Kiviat NC, Smith A, Minna JD, Ashfaq R, Gazdar AF. Toyooka KO, et al. Am J Pathol. 2002 Aug;161(2):629-34. doi: 10.1016/S0002-9440(10)64218-6. Am J Pathol. 2002. PMID: 12163387 Free PMC article.

6

Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer.

Toyooka S, Maruyama R, Toyooka KO, McLerran D, Feng Z, Fukuyama Y, Virmani AK, Zochbauer-Muller S, Tsukuda K, Sugio K, Shimizu N, Shimizu K, Lee H, Chen CY, Fong KM, Gilcrease M, Roth JA, Minna JD, Gazdar AF. Toyooka S, et al. Among authors: toyooka ko. Int J Cancer. 2003 Jan 10;103(2):153-60. doi: 10.1002/ijc.10787. Int J Cancer. 2003. PMID: 12455028

7

Epigenetic down-regulation of death-associated protein kinase in lung cancers.

Toyooka S, Toyooka KO, Miyajima K, Reddy JL, Toyota M, Sathyanarayana UG, Padar A, Tockman MS, Lam S, Shivapurkar N, Gazdar AF. Toyooka S, et al. Among authors: toyooka ko. Clin Cancer Res. 2003 Aug 1;9(8):3034-41. Clin Cancer Res. 2003. PMID: 12912953

8

Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers.

Zöchbauer-Müller S, Lam S, Toyooka S, Virmani AK, Toyooka KO, Seidl S, Minna JD, Gazdar AF. Zöchbauer-Müller S, et al. Among authors: toyooka ko. Int J Cancer. 2003 Nov 20;107(4):612-6. doi: 10.1002/ijc.11458. Int J Cancer. 2003. PMID: 14520700

9

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types.

Shivapurkar N, Toyooka S, Toyooka KO, Reddy J, Miyajima K, Suzuki M, Shigematsu H, Takahashi T, Parikh G, Pass HI, Chaudhary PM, Gazdar AF. Shivapurkar N, et al. Among authors: toyooka ko. Int J Cancer. 2004 May 1;109(5):786-92. doi: 10.1002/ijc.20041. Int J Cancer. 2004. PMID: 14999791

10

Promoter hypermethylation profile of ovarian epithelial neoplasms.

Makarla PB, Saboorian MH, Ashfaq R, Toyooka KO, Toyooka S, Minna JD, Gazdar AF, Schorge JO. Makarla PB, et al. Among authors: toyooka ko. Clin Cancer Res. 2005 Aug 1;11(15):5365-9. doi: 10.1158/1078-0432.CCR-04-2455. Clin Cancer Res. 2005. PMID: 16061849

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters